Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CIR Expert Panel Announces New Blood Ahead Of 161st Meeting

Jun 16 2022

• By Lauren Nardella

Related Content

FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims

May 02 2011

CIR Affirms Previous AHA Conclusions, Issues Seven Final Safety Reports

Dec 23 2013

Making Cosmetics Reform Beneficial For All; Former FDA Cosmetics Director Yearns For ‘Serious Sit-Down’

Jun 13 2022

CIR Panel Throws Up Hands At Airbrush Ingredient Safety, Defers To FDA On Eyelash ‘Enhancers’

Mar 21 2022

EU Commission Wants Expert Opinion On Prostaglandin Analogs In Eyelash Growth Cosmetics

Jan 21 2021

Additional Topics

United States Cosmetic Ingredients Safety Cosmetics Consumer

More from Ingredients & Safety

More from HBW Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window